microdosing with glp 1 GLP-1 is experimental and unauthorized Should Everyone be Microdosing GLP-1s?

GLP-1 (Semaglutide): Reduces appetite Slows gastric emptying Increases satiety Supports sustainable calorie reduction Average weight loss: Up to 15% in 68 weeks (NEJM 2021) GLP-1 + GIP (Tirzepatide): GLP-1 + GIP synergy boosts insulin sensitivity Enhances metabolic balance Further suppresses appetite and cravings Average weight loss: Up to 21% in 72 weeks (SURMOUNT-1) Compounded vs

NutriGenesis cultured nutrients include cofactors, enzymes and probiotics that enhance their bioavailability, metabolism and utilization

This affects the ability of cells to move and change shape, which is crucial for wound healing and tissue regeneration [35]

GLP 1 medications function as effective surgical pre-treatment options for particular patients who require them but they fail to deliver the long-term weight reduction that bariatric surgery provides to obese patients

Mck et al., 2021), demyelination is a constant finding in both white and gray matter regions pointing to the myelinating unit (the myelin sheath and oligodendrocyte) as a key target in this disease

Allen Cunningham, Co-Founder & Chief Operating Officer